Starting any minute now! For today’s #PaulKornerSeminar, Jeanette Villanueva @jvillanueva01 from the #TransplantationLab is tackling donor heart scarcity: Can the anti-diabetic drug #empagliflozin, an #SGLT2i, be used to help improve #donorheart preservation? #WomenInScience
0
0
0
0